National Cancer Institute; Notice of Closed Meetings, 30933-30934 [2013-12254]

Download as PDF Federal Register / Vol. 78, No. 100 / Thursday, May 23, 2013 / Notices Federal Register on May 14, 2013, 78 FR 11346. Meeting has been canceled. Dated: May 17, 2013. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–12255 Filed 5–22–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, June 7, 2013, 9:00 a.m. to June 7, 2013, 10:00 a.m., National Institutes of Health, National Cancer Institute, 9609 Medical Center Drive, Room 7W640, Rockville, MD, 20850 which was published in the Federal Register on May 14, 2013, 78 FR 11346. This notice is being amended due to a change in the meeting name and time to ‘‘NCI: Development of Devices for Point of Care Analysis of Circulating Tumor Cells’’ at 9:30 a.m. to 1:00 p.m. on June 7, 2013. The meeting is closed to the public. Dated: May 17, 2013. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–12256 Filed 5–22–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health sroberts on DSK5SPTVN1PROD with NOTICES National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications/ contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. VerDate Mar<15>2010 18:14 May 22, 2013 Jkt 229001 Name of Committee: National Cancer Institute Special Emphasis Panel; Topic 306 Development of Innovative Algorithms/ Software for Processing & Analysis of In Vivo Images in Oncology. Date: June 14, 2013. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute Shady Grove, Shady Grove, 9609 Medical Center Drive, Room 4W032 ,Rockville, MD 20850, (Telephone Conference Call). Contact Person: Clifford W Schweinfest, Ph.D., Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W108, Bethesda, Md 20892–9750, 240–276– 6378, schweinfestcw@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; NanotechBiosensor Platforms for Cancer. Date: June 19, 2013. Time: 3:00 p.m. to 5:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute Shady Grove, Shady Grove, 9609 Medical Center Drive, Room 6W032, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Christopher L. Hatch, Ph.D., Chief, Health Scientist Administrator, Program Coordination and Referral Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W554, Bethesda, MD 20892– 9750, 240–276–6454, hatchc@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Development of Glycosylation-Specific Research Reagents (Antibodies and Aptamers). Date: July 2, 2013. Time: 10:00 a.m. to 2:30 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute Shady Grove, Shady Grove, 9609 Medical Center Drive, Room 7W034, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Marvin L. Salin, Ph.D., Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W236, Bethesda, MD 20892–9750, 240–276–6369, msalin@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; T32 Application Review. Date: July 8, 2013. Time: 12:00 p.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, Shady Grove, 9609 Medical Center Drive, Room 7W030, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Robert Bird, Ph.D., Chief, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W110, Bethesda, MD 20892– 9750, 240–276–6344, birdr@mail.nih.gov. PO 00000 Frm 00092 Fmt 4703 Sfmt 4703 30933 Name of Committee: National Cancer Institute Special Emphasis Panel; Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology & Early Detection. Date: July 9, 2013. Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, Shady Grove, 9609 Medical Center Drive, Room 7W034, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Donald L Coppock, Ph.D., Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W260, Bethesda, MD 20892, 240–276–6382, donald.coppock@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Validation and Advanced Development of Emerging Molecular Analysis Technologies for Cancer Research. Date: July 17, 2013. Time: 12:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, Shady Grove, 9609 Medical Center Drive, Room 7W034, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Timothy C. Meeker, MD, Ph.D., Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W606, Bethesda, MD 20892, 240– 276–6454, Meekert@Mail.Nih.Gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Feasibility Studies to Build Collaborative Partnerships in Cancer Research. Date: July 23, 2013. Time: 10:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, Shady Grove, 9609 Medical Center Drive, Room 5W030, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Gerald G. Lovinger, Ph.D., Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W266, Bethesda, MD 20892–8329, 240–276–6385, lovingeg@mail.nih.gov. Information is also available on the Institute’s/Center’s home page: https:// deainfo.nci.nih.gov/advisory/sep/sep.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) E:\FR\FM\23MYN1.SGM 23MYN1 30934 Federal Register / Vol. 78, No. 100 / Thursday, May 23, 2013 / Notices Dated: May 17, 2013. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–12254 Filed 5–22–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY U.S. Customs And Border Protection Agency Information Collection Activities: Customs-Trade Partnership Against Terrorism (C–TPAT) U.S. Customs and Border Protection (CBP), Department of Homeland Security. ACTION: 60-Day notice and request for comments; Extension of an existing information collection: 1651–0077. sroberts on DSK5SPTVN1PROD with NOTICES AGENCY: SUMMARY: As part of its continuing effort to reduce paperwork and respondent burden, CBP invites the general public and other Federal agencies to comment on an information collection requirement concerning the CustomsTrade Partnership Against Terrorism (C–TPAT). This request for comment is being made pursuant to the Paperwork Reduction Act of 1995 (Pub. L. 104–13; 44 U.S.C. 3505(c)(2)). DATES: Written comments should be received on or before July 22, 2013, to be assured of consideration. ADDRESSES: Direct all written comments to U.S. Customs and Border Protection, Attn: Tracey Denning, Regulations and Rulings, Office of International Trade, 90 K Street NE., 10th Floor, Washington, DC 20229–1177. FOR FURTHER INFORMATION CONTACT: Requests for additional information should be directed to Tracey Denning, U.S. Customs and Border Protection, Regulations and Rulings, Office of International Trade, 90 K Street NE., 10th Floor, Washington, DC 20229– 1177, at 202–325–0265. SUPPLEMENTARY INFORMATION: CBP invites the general public and other Federal agencies to comment on proposed and/or continuing information collections pursuant to the Paperwork Reduction Act of 1995 (Pub. L. 104–13; 44 U.S.C. 3505(c)(2)). The comments should address: (a) Whether the collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimates of the burden of the collection of information; (c) ways to enhance the quality, utility, and clarity VerDate Mar<15>2010 18:14 May 22, 2013 Jkt 229001 of the information to be collected; (d) ways to minimize the burden including the use of automated collection techniques or the use of other forms of information technology; and (e) estimates of capital or start-up costs and costs of operations, maintenance, and purchase of services to provide information. The comments that are submitted will be summarized and included in the request for Office of Management and Budget (OMB) approval. All comments will become a matter of public record. In this document CBP is soliciting comments concerning the following information collection: Title: Customs-Trade Partnership Against Terrorism (C–TPAT). OMB Number: 1651–0077. Form Number: None. Abstract: The Customs-Trade Partnership Against Terrorism (C– TPAT) Program is designed to safeguard the world’s trade industry from terrorists and smugglers by prescreening its participants. The C–TPAT Program applies to United States importers, customs brokers, consolidators, port and terminal operators, carriers and foreign manufacturers. Respondents apply to participate in C–TPAT using an on-line application at https://ctpat.cbp.dhs.gov/ CompanyProfile.aspx. The information collected includes the applicant’s contact information and business information including the number of employees, the number of years in business, and a list of company officers. This information collection was authorized by the SAFE Port Act (Pub. L.109–347). Current Actions: This submission is being made to extend the expiration date with a change to the burden hours as a result of updated estimates for the number of annual respondents. There is no change to the C–TPAT application or to the information collected. Type of Review: Extension (with change). Affected Public: Businesses. Estimated Number of Respondents: 2,541. Estimated Time per Respondent: 5 hours. Estimated Total Annual Hours: 12,705. Dated: May 20, 2013. Tracey Denning, Agency Clearance Officer, U.S. Customs and Border Protection. [FR Doc. 2013–12327 Filed 5–22–13; 8:45 am] BILLING CODE 9111–14–P PO 00000 Frm 00093 Fmt 4703 Sfmt 4703 INTERNATIONAL TRADE COMMISSION [Docket No 2956] Certain Consumer Electronics With Display and Processing Capabilities; Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest U.S. International Trade Commission. ACTION: Notice. AGENCY: SUMMARY: Notice is hereby given that the U.S. International Trade Commission has received a complaint entitled Certain Consumer Electronics with Display and Processing Capabilities, DN 2956; the Commission is soliciting comments on any public interest issues raised by the complaint or complainant’s filing under section 210.8(b) of the Commission’s Rules of Practice and Procedure (19 CFR 210.8(b)). FOR FURTHER INFORMATION CONTACT: Lisa R. Barton, Acting Secretary to the Commission, U.S. International Trade Commission, 500 E Street SW., Washington, DC 20436, telephone (202) 205–2000. The public version of the complaint can be accessed on the Commission’s Electronic Document Information System (EDIS) at EDIS,1 and will be available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW., Washington, DC 20436, telephone (202) 205–2000. General information concerning the Commission may also be obtained by accessing its Internet server at United States International Trade Commission (USITC) at USITC.2 The public record for this investigation may be viewed on the Commission’s Electronic Document Information System (EDIS) at EDIS.3 Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on (202) 205–1810. SUPPLEMENTARY INFORMATION: The Commission has received a complaint and a submission pursuant to section 210.8(b) of the Commission’s Rules of Practice and Procedure filed on behalf of Graphics Properties Holdings, Inc. on May 17, 2013. The complaint alleges violations of section 337 of the Tariff 1 Electronic Document Information System (EDIS): https://edis.usitc.gov. 2 United States International Trade Commission (USITC): https://edis.usitc.gov. 3 Electronic Document Information System (EDIS): https://edis.usitc.gov. E:\FR\FM\23MYN1.SGM 23MYN1

Agencies

[Federal Register Volume 78, Number 100 (Thursday, May 23, 2013)]
[Notices]
[Pages 30933-30934]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-12254]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications/contract proposals and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Topic 306 Development of Innovative Algorithms/Software for 
Processing & Analysis of In Vivo Images in Oncology.
    Date: June 14, 2013.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute Shady Grove, Shady Grove, 9609 
Medical Center Drive, Room 4W032 ,Rockville, MD 20850, (Telephone 
Conference Call).
    Contact Person: Clifford W Schweinfest, Ph.D., Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, 9609 Medical Center Drive, 
Room 7W108, Bethesda, Md 20892-9750, 240-276-6378, 
schweinfestcw@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Nanotech-Biosensor Platforms for Cancer.
    Date: June 19, 2013.
    Time: 3:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute Shady Grove, Shady Grove, 9609 
Medical Center Drive, Room 6W032, Rockville, MD 20850, (Telephone 
Conference Call).
    Contact Person: Christopher L. Hatch, Ph.D., Chief, Health 
Scientist Administrator, Program Coordination and Referral Branch, 
Division of Extramural Activities, National Cancer Institute, NIH, 
9609 Medical Center Drive, Room 7W554, Bethesda, MD 20892-9750, 240-
276-6454, hatchc@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Development of Glycosylation-Specific Research Reagents 
(Antibodies and Aptamers).
    Date: July 2, 2013.
    Time: 10:00 a.m. to 2:30 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute Shady Grove, Shady Grove, 9609 
Medical Center Drive, Room 7W034, Rockville, MD 20850, (Telephone 
Conference Call).
    Contact Person: Marvin L. Salin, Ph.D., Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W236, Bethesda, MD 20892-9750, 240-276-6369, 
msalin@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; T32 Application Review.
    Date: July 8, 2013.
    Time: 12:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, Shady Grove, 9609 
Medical Center Drive, Room 7W030, Rockville, MD 20850, (Telephone 
Conference Call).
    Contact Person: Robert Bird, Ph.D., Chief, Resources and 
Training Review Branch, Division of Extramural Activities, National 
Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W110, 
Bethesda, MD 20892-9750, 240-276-6344, birdr@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Utilizing the PLCO Biospecimens Resource to Bridge Gaps in 
Cancer Etiology & Early Detection.
    Date: July 9, 2013.
    Time: 12:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, Shady Grove, 9609 
Medical Center Drive, Room 7W034, Rockville, MD 20850, (Telephone 
Conference Call).
    Contact Person: Donald L Coppock, Ph.D., Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W260, Bethesda, MD 20892, 240-276-6382, 
donald.coppock@nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Validation and Advanced Development of Emerging Molecular 
Analysis Technologies for Cancer Research.
    Date: July 17, 2013.
    Time: 12:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, Shady Grove, 9609 
Medical Center Drive, Room 7W034, Rockville, MD 20850, (Telephone 
Conference Call).
    Contact Person: Timothy C. Meeker, MD, Ph.D., Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W606, Bethesda, MD 20892, 240-276-6454, 
Meekert@Mail.Nih.Gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Feasibility Studies to Build Collaborative Partnerships in 
Cancer Research.
    Date: July 23, 2013.
    Time: 10:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, Shady Grove, 9609 
Medical Center Drive, Room 5W030, Rockville, MD 20850, (Telephone 
Conference Call).
    Contact Person: Gerald G. Lovinger, Ph.D., Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, 9609 Medical Center Drive, 
Room 7W266, Bethesda, MD 20892-8329, 240-276-6385, 
lovingeg@mail.nih.gov.

    Information is also available on the Institute's/Center's home 
page: https://deainfo.nci.nih.gov/advisory/sep/sep.htm, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)



[[Page 30934]]


    Dated: May 17, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-12254 Filed 5-22-13; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.